(Q32055417)

English

Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 July 2017

Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial (English)

1 reference

Europe PubMed Central

6 July 2017

phase III clinical trial

0 references

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

William A Robinson

7

object named as

Robinson WA

2 references

ORCID Public Data File 2021

Europe PubMed Central

6 July 2017

Charles M. Balch

3

object named as

Balch CM

1 reference

Europe PubMed Central

6 July 2017

author name string

Wallack MK

1

1 reference

Europe PubMed Central

6 July 2017

Sivanandham M

2

1 reference

Europe PubMed Central

6 July 2017

Urist MM

4

1 reference

Europe PubMed Central

6 July 2017

Bland KI

5

1 reference

Europe PubMed Central

6 July 2017

Murray D

6

1 reference

Europe PubMed Central

6 July 2017

Flaherty L

8

1 reference

Europe PubMed Central

6 July 2017

Richards JM

9

1 reference

Europe PubMed Central

6 July 2017

Bartolucci AA

10

1 reference

Europe PubMed Central

6 July 2017

Rosen L

11

1 reference

Europe PubMed Central

6 July 2017

publication date

1 July 1998

1 reference

Europe PubMed Central

6 July 2017

Journal of the American College of Surgeons

1 reference

Europe PubMed Central

6 July 2017

187

1 reference

Europe PubMed Central

6 July 2017

69-77; discussion 77-9

1 reference

Europe PubMed Central

6 July 2017

1

1 reference

Europe PubMed Central

6 July 2017

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of primary melanoma with metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial studies of autologous antibody reactivity to melanoma. Relationship to clinical course and circulating immune complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Approaches to augmenting the IgG antibody response to melanoma ganglioside vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibodies MK2-23. Experimental studies and clinical trials in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between immune response to melanoma vaccine immunization and clinical outcome in stage II malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Active specific immunotherapy in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A Southeastern Cancer Study Group phase I/II trial with vaccinia melanoma oncolysates

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Active immunotherapy with viral lysates of micrometastases following surgical removal of high risk melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive relationship of clinical and serologic responses to vaccinia melanoma oncolysate

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy of Malignant Melanoma With Vaccinia Virus

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study on the postsurgical management of Stage II malignant melanoma with a Newcastle disease virus oncolysate

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Serological response of melanoma patients to vaccines prepared from VSV lysates of autologous and allogeneic cultured melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Favorable clinical responses in subsets of patients from a randomized, multi-institutional melanoma vaccine trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of murine hepatic metastases with vaccinia colon oncolysates and IL-2

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Active specific immunotherapy with vaccinia colon oncolysate enhances the immunomodulatory and antitumor effects of interleukin-2 and interferon alpha in a murine hepatic metastasis model

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased effectiveness of interferon alfa-2b following active specific immunotherapy for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2898%2900097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1072-7515(98)00097-0

1 reference

Europe PubMed Central

6 July 2017

1 reference

Europe PubMed Central

6 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32055417&oldid=1991040126"